All In MedTech

FDA Clearance Tracker · P230023-S005

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 18, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 18, 2024

Approved

Time to decision

31 days

Received Oct 18, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P230023-S005
Device name
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Applicant location
Flagstaff, AZ
Received
Oct 18, 2024
Decided
Nov 18, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P230023

Device type

Device class
Class III

Every decision under product code QZK

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site W. L. Gore & Associates, Inc. located at 32360 N. North Valley Pkwy Phoenix AZ, 85085-4228 for manufacture and packaging of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Aortic Component (implant and delivery system).

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.